The predominant route of HIV transmission occurs across mucosal tissues. The earliest events that occur at the sites of transmission are poorly understood, yet an understanding of these events may provide critically important information that can be utilized in the development of an effective HIV vaccine. Multiple lines of investigation reveal that transmission of HIV across mucosal surfaces is inefficient. The virus must overcome multiple structural barriers and ultimately infect metabolically active CD4+ T cells. The process of infection requires that the HIV envelope protein first binds to the CD4 receptor and subsequently to a co-receptor, either CCR5 or CXCR4. However, the CD4 receptor is expressed at high levels not just on metabolically activated cells, but also on resting cells, which are a poor substrate for productive infection. We have identified the integrin alpha4-beta7 as an additional HIV receptor on the surface of CD4+ T cells. Unlike the CD4 receptor, integrin alpha4-beta7 is expressed on a subset of cells in mucosal tissues that tend to be metabolically activated. We hypothesize that the direct interaction between HIV gp120 and alpha4-beta7 provides two advantages to HIV that allow it to transmit across mucosal surfaces in a more efficient manner. By engaging alpha4-beta7 on a susceptible cell, a virion is able to target an important subset of CD4+ T cells that is highly susceptible to infection. In addition, alpha4-beta7+ CD4+ T cells migrate from genital mucosa into gut lymphoid tissues where an optimal cellular environment exists for viral replication. In this way, the specific affinity of the HIV envelope for alpha4-beta7 provides a plausible mechanistic explanation for the preferential establishment and/or maintenance of HIV replication in GALT. Understanding the specific molecular events surrounding mucosal transmission will hopefully allow us to identify new strategies to prevent HIV transmission.

Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
2013
Total Cost
$702,068
Indirect Cost
City
State
Country
Zip Code
Guzzo, Christina; Ichikawa, David; Park, Chung et al. (2017) Virion incorporation of integrin ?4?7 facilitates HIV-1 infection and intestinal homing. Sci Immunol 2:
Kijak, Gustavo H; Sanders-Buell, Eric; Chenine, Agnes-Laurence et al. (2017) Rare HIV-1 transmitted/founder lineages identified by deep viral sequencing contribute to rapid shifts in dominant quasispecies during acute and early infection. PLoS Pathog 13:e1006510
Girard, Alexandre; Jelicic, Katija; Van Ryk, Don et al. (2017) Neutralizing and Targeting Properties of a New Set of ?4?7-Specific Antibodies Are Influenced by Their Isotype. J Acquir Immune Defic Syndr 75:118-127
Plotnik, David; Guo, Wenjin; Cleveland, Brad et al. (2017) Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with ?4?7. J Virol 91:
Byrareddy, Siddappa N; Arthos, James; Cicala, Claudia et al. (2016) Sustained virologic control in SIV+ macaques after antiretroviral and ?4?7 antibody therapy. Science 354:197-202
Deng, Jing; Mitsuki, Yu-Ya; Shen, Guomiao et al. (2016) HIV Envelope gp120 Alters T Cell Receptor Mobilization in the Immunological Synapse of Uninfected CD4 T Cells and Augments T Cell Activation. J Virol 90:10513-10526
Cicala, Claudia; Nawaz, Fatima; Jelicic, Katija et al. (2016) HIV-1 gp120: A Target for Therapeutics and Vaccine Design. Curr Drug Targets 17:122-35
Arrode-Brusés, Géraldine; Goode, Diana; Kleinbeck, Kyle et al. (2016) A Small Molecule, Which Competes with MAdCAM-1, Activates Integrin ?4?7 and Fails to Prevent Mucosal Transmission of SHIV-SF162P3. PLoS Pathog 12:e1005720
Hait, Sabrina H; Soares, Esmeralda A; Sprinz, Eduardo et al. (2015) Worldwide Genetic Features of HIV-1 Env ?4?7 Binding Motif: The Local Dissemination Impact of the LDI Tripeptide. J Acquir Immune Defic Syndr 70:463-71
Kwon, Young Do; Pancera, Marie; Acharya, Priyamvada et al. (2015) Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env. Nat Struct Mol Biol 22:522-31

Showing the most recent 10 out of 34 publications